FDA approves 2006 strain of flu vaccine

August 3, 2006

The U.S. Food and Drug Administration has approved the manufacture of this year's seasonal influenza vaccine.

The vaccine is designed to fight new virus strains scientists believe are likely to cause flu in the Northern Hemisphere during 2006-07.

Each year influenza vaccine manufacturers submit information and samples to the FDA of the virus strains to be produced for the upcoming seasonal influenza season. This season's FDA-approved formulation is identical to that recommended by the World Health Organization. The formulation includes one strain that was used in last year's vaccine and two new strains.

Seasonal flu vaccines do not protect against avian influenza, which is caused by different viral strains.

The U.S. Centers for Disease Control and Prevention say up to 20 percent of the U.S. population is stricken by influenza annually, with about 200,000 people requiring hospitalization and approximately 36,000 people dying from the disease.

At high risk for serious flu complications are elderly people, children and people with certain chronic medical conditions.

Copyright 2006 by United Press International

Explore further: Dog owners urged to vaccinate pets against new flu

Related Stories

Dog owners urged to vaccinate pets against new flu

November 26, 2015

A virologist at the College of Veterinary Medicine urges dog owners to take advantage of a new vaccine to protect against H3N2, the strain of canine influenza that sickened hundreds of dogs in the Chicago area last March ...

Recommended for you

Can Paris pledges avert severe climate change?

November 26, 2015

More than 190 countries are meeting in Paris next week to create a durable framework for addressing climate change and to implement a process to reduce greenhouse gases over time. A key part of this agreement would be the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.